Turn this list into pipeline.
Generic Medicines Companies in the UK: 100+ Active Firms (2026)
Generic medicines companies develop, license and supply bioequivalent off-patent treatments under UK MHRA oversight.
Procurement, regulatory affairs and quality teams tend to be the main buying centres, rather than brand marketing or early-stage discovery. Sales run through hospital, pharmacy, wholesale and public-sector healthcare channels, so qualification is often about licences, pharmacovigilance cover, batch release, continuity of supply and price discipline. Buyers are usually institutional or B2B purchasers managing formularies, tenders and distributed prescribing volumes. Engagements are correspondingly operational: supplier approvals, portfolio-level agreements, import and distribution arrangements, and recurring procurement cycles across multiple therapeutic areas. The closest-fit firms are mid-market and larger operators focused on off-patent, biosimilar or value-added medicines, not speculative patent-led research.
Read more
The UK cohort is small but specialised, with 133 actively trading companies in this list. Reported employment totals 2,025 people across 114 firms, with every firm in that reporting group giving a headcount. Scale is uneven: 38 companies report more than £5M in turnover, while 17 were incorporated since 2022. That mix points to a market where established licence holders and suppliers sit alongside newer entrants, but the operational burden of marketing authorisations, pharmacovigilance and distribution tends to favour firms with existing quality systems and wholesale relationships.
Human medicines sit within the MHRA regime, and generic suppliers cannot treat market entry as a simple trading registration. UK-wide marketing authorisations, pharmacovigilance responsibilities and quality-assurance controls shape who can manufacture, import, release and distribute products. Generic applications are tied to the Human Medicines Regulations, with the core test being sameness of active substance and pharmaceutical form, plus bioequivalence to a reference medicinal product. Market structure is also shaped by NHS procurement and by representation through Medicines UK, the trade body for off-patent generic, biosimilar and value-added medicines.
Future movement appears more likely to come from portfolio rationalisation, tender dynamics and compliance load than from speculative discovery cycles. Smaller suppliers tend to face the same authorisation, safety-monitoring and quality obligations as better resourced peers, which can make narrow portfolios exposed when prices tighten or supply issues arise. Scale-up scarcity is therefore plausible: firms that already manage regulated distribution, NHS-facing procurement and multiple therapeutic areas have an easier route to adding products. Consolidation may continue where licence ownership, import capability and wholesale access can be combined without weakening supply continuity.
133
Active firms
2026
38
Over £5M revenue
Larger operators
17
Incorporated since 2022
Recent formations
Key facts
About 28% of the trading cohort reports turnover above £5M (38 of 133 firms) — the rest sits below that revenue band.
12% of the cohort was incorporated since 2022 (17 firms), so a sizeable share is in its first few filing cycles.
From 1 January 2025, the MHRA licenses human medicines across the whole UK through UK-wide marketing authorisations.
UK-wide generic applications under Regulation 51B of the Human Medicines Regulations 2012 must show the same active substance, the same pharmaceutical form and bioequivalence to the reference medicinal product.
Medicines UK says generic, biosimilar and value-added medicines deliver more than £20 billion in annual savings to healthcare budgets.
Medicines UK says its members manufacture and supply 85% of the prescription medicines used by the NHS.
OECD comparisons put generics at more than three-quarters of UK pharmaceutical volume in 2021, with later comparisons putting the UK above 50% of pharmaceutical-market value.
Top UK generic medicines companies
CRESCENT PHARMACEUTICALS LIMITED
Trajectory
3y · 2019–NowFinancial sub-scores
Computed from 3 filingsManufactures and distributes generic pharmaceutical medicines. Operates manufacturing, R&D and warehousing facilities, supplying tablet and liquid medicines through wholesalers and distributors to…
Serves B2B and public-sector healthcare buyers in the UK, including the NHS, Department of Health, wholesalers, distributors, pharmacies, hospitals, clinics and other healthcare providers; also…
Financial Health
DistressedDistressed
Location
CHARLWOOD PHARMA LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsManufactures and distributes generic prescription medicines through retail pharmacy, wholesale and hospital channels. Develops and markets pharmaceutical products across therapeutic areas including…
Sells to UK healthcare channels, primarily retail pharmacies, pharmaceutical wholesalers and hospitals, supplying prescription medicines across therapeutic areas including cardiovascular, CNS,…
Financial Health
HealthyHealthy · 0% CAGR over 2y
Location
Develops, manufactures and supplies generic, biosimilar and specialty medicines and biopharmaceuticals. Provides treatments across areas including central nervous system disorders, migraine,…
Serves the NHS and UK healthcare organisations, with a patient base across CNS, migraine, respiratory, oncology, pain and consumer health; also addresses UK patients and caregivers seeking medicine…
Location
Develops, manufactures and supplies generic, biosimilar and specialty pharmaceutical medicines. Produces treatments across areas such as central nervous system, migraine, respiratory, oncology and…
Serves the NHS and wider UK healthcare system, including healthcare professionals and organisations involved in patient care, while also addressing patients and caregivers across CNS, migraine,…
Location
Develops, manufactures and supplies generic, biosimilar and specialty medicines, including treatments for central nervous system, respiratory, oncology and pain conditions. Also provides…
Serves the NHS and UK healthcare providers, with resources aimed at patients and caregivers managing conditions across areas such as central nervous system disorders, migraine, respiratory disease,…
Location
CRESCENT PHARMA LIMITED
Trajectory
3y · 2020–NowFinancial sub-scores
Computed from 3 filingsManufactures and distributes generic pharmaceutical medicines. Produces solid and liquid drug formulations, manages marketing authorisations, and supplies medicines to wholesalers, pharmacies,…
Sells B2B to the UK healthcare supply chain, including the NHS, Department of Health, wholesalers, distributors, pharmacies, hospitals, clinics and retail outlets. Also serves export customers and…
Financial Health
HealthyHealthy · Profitable · -10% CAGR over 2y
Location
CLYDESDALE PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and wholesales generic pharmaceutical medicines. Imports, batch tests, releases, stores and distributes prescription and over‑the‑counter drugs, supplying the UK market and exporting…
Serves B2B pharmaceutical customers in the UK and internationally, including wholesalers, distributors and healthcare supply-chain buyers sourcing generic prescription, pharmacy and general-sale…
Financial Health
StrongStrong · Growing, Hiring · 73% CAGR over 4y
Location
Supplies generic prescription medicines to retail pharmacies, wholesalers and hospitals. Develops and markets a portfolio of pharmaceutical products across therapeutic areas including cardiovascular,…
Serves the UK healthcare supply chain, including retail pharmacies, pharmaceutical wholesalers and hospitals procuring generic prescription medicines.
Location
BRISTOL LABORATORIES LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops, manufactures, and distributes generic pharmaceutical medicines for the healthcare sector. Produces and supplies prescription and consumer healthcare products including treatments for…
Sells B2B to healthcare-sector organisations, including medicine wholesalers, pharmacies, hospitals and distributors, primarily in the UK with wider European and international customer markets…
Financial Health
HealthyHealthy · Hiring · 11% CAGR over 1y
Location
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, markets and distributes generic pharmaceutical medicines. Supplies a range of prescription drugs including analgesics, cardiovascular and antibiotic treatments such as…
Serves NHS contractors, pharmaceutical suppliers and wholesale/distribution buyers in the UK market for generic medicines.
Financial Health
WeakWeak
Location
BRISTOL CONSUMER HEALTH LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures and supplies generic and consumer healthcare medicines. Activities include pharmaceutical product development, regulatory compliance, manufacturing, packaging and…
Serves consumers, patients and healthcare-sector buyers across therapeutic areas including gastrointestinal health, cold and flu, CNS, cardiovascular care and
Financial Health
DistressedDistressed
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, in-licenses, manufactures and markets pharmaceutical products, focusing on generic and specialty medicines. Operates research and development and manufacturing for products including…
Serves healthcare markets with generic and specialty pharmaceutical products, selling primarily to healthcare providers, pharmacies and pharmaceutical distribution channels, while also partnering…
Financial Health
StableStable · 0% CAGR over 2y
Location
Dr Reddy's Laboratories (EU) Limited
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops, manufactures and supplies generic medicines, biosimilars and active pharmaceutical ingredients. Provides pharmaceutical development and manufacturing services and markets specialty,…
Serves healthcare providers, patients, pharmacies and consumers, with B2B relationships with pharmaceutical companies needing APIs, development, manufacturing and research support across global…
Financial Health
HealthyHealthy · Hiring · 4% CAGR over 3y
Location
NOUMED LIFE SCIENCES LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures, packages and distributes generic pharmaceutical products. Operates facilities for dosage‑form production, quality control testing, regulatory compliance and warehousing, and markets…
Serves UK healthcare and pharmaceutical-sector customers, including organisations sourcing generic medicines and related life sciences products.
Financial Health
WeakWeak · -63% CAGR over 4y
Location
ASPIRE PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, acquires and supplies generic and specialty pharmaceutical medicines. Manages a portfolio of prescription products across therapeutic areas including cardiology, dermatology, oncology and…
Serves patients, healthcare professionals and national health systems in the UK and internationally, across specialist therapeutic areas including cardiology, dermatology, oncology, ophthalmology,…
Financial Health
HealthyHealthy · Hiring · 15% CAGR over 4y
Location
Alissa Healthcare Research Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops, licenses, markets and distributes generic and speciality medicines. Supplies pharmaceutical products to healthcare providers and pharmacies and collaborates with partners to bring licensed…
Sells to UK healthcare buyers, particularly the NHS and pharmacies, and serves pharmaceutical customers and collaboration partners in the UK, EU and worldwide. Targets B2B and public sector medicine…
Financial Health
HealthyHealthy · -3% CAGR over 4y
Location
BROWN & BURK UK LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures, markets and distributes generic pharmaceutical medicines. Supplies EU GMP‑compliant products including antibiotics and other prescription drugs, and manages pharmaceutical supply chains…
Serves B2B healthcare and pharmaceutical buyers, including distributors and supply-chain partners sourcing generic medicinal products across the UK and Europe.
Financial Health
HealthyHealthy · -51% CAGR over 5y
Location
Ria Generics Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures and wholesales generic pharmaceutical products. Acts as a marketing authorisation holder, importer and batch‑release site, and supplies licensed and unlicensed medicinal products to…
Serves pharmaceutical distributors and approved wholesale dealers in the UK and Europe, plus non-EU/UK brands requiring licensed or unlicensed generic medicines under their own label.
Financial Health
StrongStrong · Growing · 0% CAGR over 5y
Location
NICHE GENERICS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures, packages and supplies generic pharmaceutical medicines. Operates facilities for solid‑dose drug manufacturing, packaging and testing, and distributes finished products through…
Sells to pharmaceutical wholesalers in the UK and selected distribution partners across Europe and other territories, serving B2B buyers in the generic medicines supply chain.
Financial Health
WeakWeak · -2% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsMarkets and supplies generic pharmaceutical medicines to wholesale distributors, pharmacies, and healthcare providers. Licenses and markets medicines from third parties and develops generic drugs…
Serves UK pharmaceutical wholesalers, retail pharmacy channels and secondary care healthcare providers, with additional relationships with third-party product licensing partners.
Financial Health
WeakWeak · Hiring · 6% CAGR over 2y
Location
Strides Pharma UK
Develops, manufactures and supplies generic and over‑the‑counter pharmaceutical products, including soft gel capsule formulations, using in‑house active pharmaceutical ingredients. Manages…
Serves UK healthcare and pharmaceutical customers, alongside patients and healthcare professionals seeking information on branded generic, generic and OTC medicines.
Location
MANX (HOLDINGS) LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops, manufactures and distributes generic and over‑the‑counter pharmaceutical products. Portfolio includes medicines across therapeutic areas such as pain relief, dental care, infection…
Serves B2B pharmaceutical buyers, including wholesalers, pharmacies and healthcare distributors, requiring generic and over-the-counter medicines in the UK and beyond.
Financial Health
StableStable
Location
Waymade
Develops, licenses, registers and commercialises generic and niche pharmaceutical medicines. Focuses on specialty therapeutic areas and manages product development and regulatory approval processes…
Serves healthcare and pharmaceutical markets globally, including organisations involved in access to generic and niche specialty medicines, with patients as the end-user population.
Location
Develops and supplies pharmaceutical products including generic, biosimilar, and specialty medicines. Produces biopharmaceutical treatments and provides medicines for areas such as CNS disorders,…
Serves the NHS and UK healthcare providers, with medicines used by patients and caregivers managing conditions including CNS, migraine, respiratory, oncology, pain and consumer health.
Location
Develops and supplies pharmaceutical products including generic medicines, specialty drugs and biosimilars, supporting the manufacture and distribution of treatments across therapeutic areas such as…
Serves the NHS and UK healthcare providers, as well as patients and caregivers seeking information and support across CNS, migraine, respiratory, oncology, pain and consumer health areas.
Location
Rivopharm UK Ltd
Trajectory
2y · 2019–NowFinancial sub-scores
Computed from 2 filingsMarkets and supplies generic pharmaceutical products to wholesale, retail, and healthcare sectors. Sources medicines from affiliated manufacturing and R&D operations and licenses additional products…
Serves UK pharmaceutical wholesale, retail pharmacy and secondary care channels, supplying generic medicines to healthcare distribution and provider organisations.
Financial Health
StableStable · 0% CAGR over 1y
Location
FLEXIPHARM AUSTRADING LIMITED
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsSupplies and distributes generic injectable medicines for critical care to NHS and independent hospitals. Focuses on vial presentations and alternative strengths of established pharmaceuticals, and…
Serves UK NHS and independent hospitals, targeting healthcare professionals, specialist procurement and quality pharmacists involved in purchasing, supplying or prescribing injectable critical care…
Financial Health
HealthyHealthy · Growing · 0% CAGR over 3y
Location
MSN Labs UK
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures and supplies pharmaceutical medicines across multiple therapeutic areas. Manages a portfolio of drug products and supports distribution, regulatory, and pharmacovigilance…
Serves healthcare organisations, pharmaceutical supply-chain partners and other health stakeholders in the UK, with patients as the end beneficiaries across multiple therapeutic areas.
Financial Health
StrongStrong · Hiring · 12% CAGR over 4y
Location
FLAMINGO PHARMA (UK) LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesales prescription and over‑the‑counter pharmaceutical products. Acquires, develops and markets generic medicines, supplying tablets, capsules and other treatments through licensing,…
Serves B2B customers in the UK pharmaceuticals market, including healthcare providers and partners seeking generic medicines, own-label supply arrangements and product availability information.
Financial Health
HealthyHealthy · -88% CAGR over 2y
Location
CELIX PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises generic and branded generic medicines and hospital specialty pharmaceuticals. Works with R&D and manufacturing partners to take products from development and regulatory…
Serves UK and European healthcare markets, selling to retail pharmacy and hospital channels, primary and secondary care providers, payers, and pharmaceutical partners.
Financial Health
HealthyHealthy
Location
TARGET HEALTHCARE INTERNATIONAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and manufactures generic, branded and unlicensed medicines to pharmacies, hospitals, dispensing doctors and wholesalers. Provides custom “specials” medicines, parallel imports, medical…
Serves pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and internationally, including healthcare providers and distributors needing licensed,…
Financial Health
StableStable · 1% CAGR over 4y
Location
Flynn Pharma
Develops, licenses and supplies branded and generic pharmaceutical medicines for primary and secondary care, covering areas such as psychiatry, paediatrics, anti‑infectives, women’s health and…
Serves UK healthcare professionals and clinical organisations across primary, secondary and speciality care, including clinicians and NHS leaders in psychiatry, paediatrics, women’s health,…
Location
Develops and supplies prescription medicines to healthcare providers and the NHS. Manages a portfolio including branded and branded‑generic pharmaceuticals and provides information and educational…
Serves the NHS and UK healthcare professionals, with patients as end users; also engages pharmaceutical business partners seeking UK market collaboration.
Location
Galvany Developments Ltd
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises niche pharmaceutical medicines across multiple therapeutic areas. Manages a portfolio of prescription drugs, including injectable treatments, and works with manufacturing…
Serves prescribers, retail pharmacies and hospital customers in the healthcare sector, with additional relationships with pharmaceutical manufacturers and commercial partners for co-development,…
Financial Health
HealthyHealthy
Location
H & K HEALTHCARE LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures and supplies pharmaceutical products including generic medicines, cardiovascular and neurological drugs, sterile injectables, paediatric formulations, and herbal nutraceuticals…
Serves healthcare professionals, hospitals, clinics and pharmaceutical buyers worldwide, including purchasers for generic, specialist, injectable, paediatric, herbal and nutraceutical healthcare…
Financial Health
HealthyHealthy · Hiring · 22% CAGR over 2y
Location
MANX HEALTHCARE LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops, manufactures and distributes generic and over‑the‑counter pharmaceutical products. Offers a portfolio including medicines for pain relief, travel health, dental care, infections, gut health…
Serves pharmaceutical buyers and healthcare supply-chain customers in the UK and beyond, focused on generic and over-the-counter medicines across therapeutic areas such as pain relief, dental,…
Financial Health
WeakWeak · 0% CAGR over 2y
Location
OCTAGENIX LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and supplies biopharmaceutical products including specialty generics, biosimilars, orphan drugs and unlicensed medicines. Conducts pharmaceutical research and development in areas such as…
Serves NHS organisations, healthcare professionals and patients needing access to specialist medicines, with emphasis on oncology, obesity, infection control, viral diseases, medical cannabis, orphan…
Financial Health
StableStable · -5% CAGR over 4y
Location
Alpha Pharma Supplies Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and supplies generic pharmaceutical products, including micronized micro‑tablet formulations. Product range covers treatments for asthma, hormone replacement therapy, oncology,…
Serves healthcare and pharmaceutical buyers in the global generic medicines market, including distributors and sellers supplying patients across multiple therapeutic areas.
Financial Health
DistressedDistressed · -7% CAGR over 3y
Location
S K PHARMACARE LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsSupplies pharmaceutical products including value‑added medicines, precision medicines, orphan drugs, and complex generics. Uses market data and supply chain analysis to select, launch, and distribute…
Serves healthcare and pharmaceutical stakeholders worldwide, including partners involved in market access, supply chains and patient access for value-added medicines, precision medicines, orphan…
Financial Health
StrongStrong
Location
IPCA LABORATORIES UK LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, and supplies pharmaceutical products including active pharmaceutical ingredients (APIs) and generic formulations. Conducts research and development and provides packaging and…
Serves B2B pharmaceutical buyers, distributors and healthcare-sector organisations seeking APIs, formulations and generics, with customers across more than 120 countries.
Financial Health
StrongStrong · Hiring · 360% CAGR over 2y
Location
GH PHARMA (UK) LTD
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops and markets generic injectable pharmaceutical products for hospital use. Engages in licensing, asset acquisitions, and partnerships for the joint development, marketing, and distribution of…
Serves hospitals and healthcare providers needing injectable pharmaceutical products, and partners with pharmaceutical and biotechnology companies for licensing, distribution, and development in…
Financial Health
WeakWeak · 0% CAGR over 3y
Location
Imed (NI)
Provides pharmaceutical wholesaling, sourcing and manufacturing of parallel‑imported branded medicines, generics and over‑the‑counter products, and distributes diagnostics, high‑tech medicines and…
Serves pharmaceutical wholesalers, hospital pharmacies, healthcare providers and public health bodies across Northern Ireland, the UK and Republic of Ireland medicines markets.
Location
EVER PHARMA UK LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures pharmaceutical products including specialty generic medicines and critical‑care injectable drugs. Provides sterile injectable formulation capabilities and contract…
Sells to healthcare organisations and pharmaceutical buyers needing specialty generics and critical-care injectables, and to pharma/biotech companies seeking sterile injectable CDMO partners.
Financial Health
StableStable · -70% CAGR over 4y
Location
BRANCASTER LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and supplies pharmaceutical medicines for clinical use, including midodrine hydrochloride (Bramox), benzylpenicillin benzathine, thiamine hydrochloride injections, and varenicline…
Serves patients with rarer conditions and the healthcare professionals involved in their treatment, particularly where listed prescription medicines are relevant.
Financial Health
DistressedDistressed · -13% CAGR over 3y
Location
NORTHUMBRIA PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops, manufactures, and licenses pharmaceutical products, including new chemical entities and generic medicines. Provides services such as pharmacovigilance, regulatory affairs…
Serves pharmaceutical companies, supply partners, healthcare providers and healthcare professionals, with products ultimately targeting patients needing affordable medicines and unmet-need therapies.
Financial Health
StableStable · -67% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops and licenses generic pharmaceutical products for human and veterinary use, focusing on complex and niche molecules. Works with contract manufacturers to produce medicines and…
Serves B2B pharmaceutical and healthcare customers, including payors, healthcare providers, wholesalers, prescribers and pharmacies, plus companies seeking licensing, acquisitions, co-development or…
Financial Health
StableStable · Hiring · 19% CAGR over 4y
Location
PHARMATHEN U.K. LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures pharmaceutical products, focusing on complex and long‑acting generic medicines. Conducts research and development, creates drug delivery technologies, and provides finished…
Serves branded pharmaceutical companies, licensors, distributors and affiliates worldwide, as well as commercial partners seeking generic product portfolios and regulatory or technical support.
Financial Health
HealthyHealthy · 7% CAGR over 1y
Location
Galvany Pharma Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and commercialises niche pharmaceutical medicines across multiple therapeutic areas. Manages a portfolio of prescription drugs, including injectable treatments, and works with manufacturing…
Serves prescribers, community pharmacies, retail pharmacy chains and hospital customers seeking niche medicines, and engages pharmaceutical manufacturers and commercial partners for co-development,…
Financial Health
WeakWeak
Location
LONDON UNITED EXPORTS LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, exports and markets off‑patent prescription medicines and consumer healthcare products. Supplies a portfolio of pharmaceutical products across multiple therapeutic categories…
Serves healthcare providers, practitioners, pharmaceutical distributors and consumer healthcare markets in major and developing markets across more than 20 countries.
Financial Health
StableStable · -90% CAGR over 2y
Location
Unlock all 133 leads
Showing 49 of 133 — +84 more with verified decision-maker contacts, live data, and CRM sync.
How UK generic medicines companies work and how to sell to them
What they do
Revenue usually comes from supplying authorised off-patent medicines into healthcare channels, rather than from discovery milestones or brand-led promotion. Generic medicine firms may hold marketing authorisations, import finished products, contract out manufacturing, manage batch release, or distribute portfolios sourced from third-party manufacturers. Pricing tends to be pack-based, tender-led or agreed through wholesaler and pharmacy terms, with volume, service levels and substitution dynamics mattering more than promotional reach. Engagements are often recurring but operationally constrained: each product line carries quality documentation, pharmacovigilance duties, expiry management and supply-continuity expectations, so revenue growth depends on adding reliable products without increasing compliance risk faster than the operating model can absorb it.
Who they sell to
Most sales go to institutional and B2B buyers: hospital procurement teams, pharmacy groups, wholesalers and public-sector purchasing bodies. The commercial buyer is often procurement-led, but regulatory affairs, quality, responsible-person functions and finance tend to influence supplier approval before volume moves. Typical contracts range from repeat purchase arrangements to portfolio-level tenders, with sales cycles shaped by product qualification, price benchmarking, service history and supply assurance. Newer suppliers may enter through narrower product lines or import arrangements, while larger operators can compete across therapeutic portfolios. Procurement is usually direct, tender-based or framework-led, rather than self-serve or marketing-led.
What they buy
Most generic medicine firms tend to spend on systems and services that reduce friction around regulated supply. Relevant categories include regulatory information management, pharmacovigilance operations, quality management, batch documentation, artwork and labelling control, ERP, inventory planning, demand forecasting, warehouse management and audit management. Firms with manufacturing or release responsibilities may also buy laboratory systems, validation support, equipment maintenance and specialist quality consultancy. Commercial teams may need tender tracking, pricing analytics, CRM and contract-management tooling, but the sale usually has to make sense to compliance and operations as well as revenue leadership. Recruitment, legal, accounting and insurance services are also common where portfolios or authorisations are changing.
Why and how to sell to them
Generic medicine buyers tend to evaluate suppliers when operating pressure rises: a new authorisation, a tender win, a supply interruption, an audit finding, a portfolio acquisition, a change in import route or a shortage of regulatory and quality staff. Margin pressure makes generic suppliers wary of discretionary spend, so outbound messages usually work better when tied to avoided stock-outs, faster batch release, fewer manual deviations, cleaner audit trails or lower tender-administration burden. The strongest angle is often operational evidence rather than category language: show how similar regulated suppliers reduce rework, maintain continuity of supply and support MHRA-facing obligations without adding another heavy process layer.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Related directories
Frequently asked questions
How many generic medicines companies are there in the UK?↓
What counts as a generic medicines company in this list?↓
Which are the largest generic medicines companies in the UK?↓
What do generic medicines companies in the UK actually do?↓
How does UK generic medicines compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical generic medicines companies in the UK?↓
Are these mostly new or established generic medicines companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 133 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.